Moderate Hypofractionation in High-Risk, Organ-Confined Prostate Cancer: Final Results of a Phase III Randomized Trial

医学 前列腺癌 四分位间距 前列腺 随机对照试验 放射治疗 泌尿生殖系统 泌尿科 剂量分馏 外科 癌症 内科学
作者
Giorgio Arcangeli,Biancamaria Saracino,Stefano Arcangeli,Sara Gomellini,Maria Grazia Petrongari,Giuseppe Sanguineti,Lidia Strigari
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:35 (17): 1891-1897 被引量:166
标识
DOI:10.1200/jco.2016.70.4189
摘要

Purpose To report the final results on treatment outcomes of a randomized trial comparing conventional and hypofractionated radiotherapy in high-risk, organ-confined prostate cancer (PCa). Patients and Methods This single-institution, randomized clinical trial, conducted from January 2003 to December 2007, enrolled 168 patients with high-risk PCa who were randomly assigned in a 1:1 ratio to conventional (80 Gy in 40 fractions in 8 weeks) or hypofractionated radiotherapy (62 Gy in 20 fractions in 5 weeks) to prostate and seminal vesicles. The primary outcome measure was late toxicity. Additional outcomes were freedom from biochemical failure (FFBF), prostate cancer–specific survival (PCaSS), and overall survival (OS), evaluated on an intention-to-treat basis. Results A total of 85 patients were assigned to conventional and 83 to hypofractionated radiotherapy. At a median follow-up of 9 years (interquartile range, 7.5 to 10.1 years), no differences was observed in physician-assessed late gastro intestinal and genitourinary toxicity greater than or equal to grade 2 ( P = .68 and .57, respectively) were found between the two arms. The 10-year FFBF rate was 72% in the hypofractionation group and 65% in the conventional fractionation group ( P = .148). Ten-year OS rates were 75% in the hypofractionation group and 64% in the conventional group, respectively ( P = .22). The same features for 10-year PCaSS were 95% and 88%, respectively ( P = .066). Hypofractionation, pretreatment prostate-specific antigen level, Gleason score, and clinical tumor stage for FFBF, and hypofractionation and Gleason score for PCaSS were significant prognostic variables on the multivariate analysis. Conclusion Long-term findings showed that hypofractionated radiotherapy failed the intent of either reducing physician-assessed late toxicity or maintaining the same efficacy. A postrandomization analysis, however, revealed that hypofractionation was a significant prognostic factor for FFBF and PCaSS, when adjusted for clinical prognostic variables.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
lulu发布了新的文献求助10
1秒前
2秒前
2秒前
3秒前
麒麟才子完成签到,获得积分10
3秒前
完美世界的应助被优秀寻凝采纳,获得10
3秒前
june发布了新的文献求助10
3秒前
5秒前
Berry完成签到,获得积分10
6秒前
还有早安完成签到,获得积分10
6秒前
阿迪大狮完成签到,获得积分10
6秒前
tingyu发布了新的文献求助10
7秒前
任性饼干完成签到,获得积分10
7秒前
7秒前
haha完成签到,获得积分10
7秒前
vegdog完成签到,获得积分10
8秒前
SciGPT的应助被zhu采纳,获得10
8秒前
sickkkk4发布了新的文献求助10
8秒前
阔达的夜山完成签到,获得积分10
9秒前
香蕉亦竹完成签到 ,获得积分10
10秒前
10秒前
Rina发布了新的文献求助10
11秒前
11秒前
风吹麦浪的应助被阿迪大狮采纳,获得10
11秒前
嗯嗯完成签到 ,获得积分10
12秒前
自由新筠完成签到,获得积分10
13秒前
初景发布了新的文献求助10
13秒前
小马甲的应助被lulu采纳,获得10
14秒前
14秒前
阿路不是鹿的应助被脏脏鲤采纳,获得10
15秒前
优秀寻凝发布了新的文献求助10
15秒前
vv完成签到,获得积分10
15秒前
16秒前
16秒前
orixero的应助被sunmeng采纳,获得10
16秒前
shy完成签到,获得积分10
17秒前
17秒前
大个的应助被obcx采纳,获得10
19秒前
yongqi完成签到,获得积分10
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Agyptische Geschichte der 21.30. Dynastie 510
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8191370
求助须知:如何正确求助?哪些是违规求助? 9578255
关于积分的说明 21857784
捐赠科研通 7790730
什么是DOI,文献DOI怎么找? 3436626
关于科研通互助平台的介绍 2560360
邀请新用户注册赠送积分活动 2483366